BMI1, Stem Cell Factor Acting as Novel Serum-biomarker for Caucasian and African-American Prostate Cancer

BACKGROUND: Lack of reliable predictive biomarkers is a stumbling block in the management of prostate cancer (CaP). Prostate-specific antigen (PSA) widely used in clinics has several caveats as a CaP biomarker. African-American CaP patients have poor prognosis than Caucasians, and notably the serum-...

Descripción completa

Detalles Bibliográficos
Autores principales: Siddique, Hifzur Rahman, Parray, Aijaz, Zhong, Weixiong, Karnes, R. Jeffery, Bergstralh, Eric J., Koochekpour, Shahriar, Rhim, Johng S., Konety, Badrinath R., Saleem, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538726/
https://www.ncbi.nlm.nih.gov/pubmed/23308129
http://dx.doi.org/10.1371/journal.pone.0052993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538726/
https://www.ncbi.nlm.nih.gov/pubmed/23308129
http://dx.doi.org/10.1371/journal.pone.0052993

Ejemplares similares